$TRUP

GALLAGHER JOHN R sold $11K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 431 shares of TRUPANION, INC. (TRUP) at $25.08 on 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jul 30, 2026, 9:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 9:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
low confidence
Mentioned
$TRUP
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The only new fact is the COO’s open-market sale details (431 shares at $25.08) under a pre-arranged 10b5-1 plan; no operational or financial guidance changes are provided.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure reduces fundamental interpretability.

03

What to watch

The article does not state total position value, prior sale cadence, or whether other insiders sold/bought around the same window, which limits inference from a single transaction.

Relevance 2/10Novelty 2/10Timing: filed 2026-07-30, sale dated 2026-07-28

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC.

Company-level read

Ticker impact

$TRUPNeutralLow confidence
Context

TRUP insider Form 4 shows COO John R. Gallagher sold 431 shares at $25.08 on 2026-07-28 under a 10b5-1 plan.

Expected impact

Likely minimal price impact; any reaction would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a scheduled open-market sale under a pre-arranged 10b5-1 plan, with no accompanying guidance, operational update, or enforcement/regulatory event disclosed.

Market effects

No clear sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Because it is a 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations, so traders may overreact if they treat it as discretionary selling.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction is disclosed on SEC Form 4.

  • GALLAGHER JOHN R

    Chief Operating Officer who sold 431 shares under a 10b5-1 plan.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin